Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01140880 · ClinicalTrials.gov registry record · Phase 2
Biobehavioral Interventions for HIV-negative, Stimulant Using Men Who Have Sex With Men
A Phase 2 study of Stimulant Abuse and HIV Seroconversion, sponsored by Friends Research Institute.
- Completed
- Registry status
- Phase 2
- Development phase
- 170
- Enrollment target
- 1
- Study location
NCT01140880: Completed Phase 2 study of Stimulant Abuse and HIV Seroconversion, sponsored by Friends Research Institute.
NCT01140880 is a Phase 2 study of Stimulant Abuse and HIV Seroconversion that has completed, run by Friends Research Institute. The registered enrollment target is 170 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (28% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01140880, a Phase 2 study of Stimulant Abuse and HIV Seroconversion, has completed, sponsored by Friends Research Institute.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 170 participants
- Enrollment target
- 1
- Study location
Study Summary
This study seeks to evaluate the efficacy of a contingency management (CM) intervention compared to a yoked control condition for eliminating illicit stimulant use and for decreasing time to initiating post exposure prophylaxis (PEP), for improving adherence to PEP, and for completing PEP following a potential HIV-exposure event. Men who have sex with men who use cocaine amphetamine or methamphetamine frequently also have high risk sexual behaviors during or after their drug use. The objective of this study evaluates whether the use of CM that targets stimulant use significantly aids men who have sex with men who use stimulants and also engage in high-risk sexual transmission behaviors to be able to initiate, adhere to and complete PEP, thereby optimizing the utility of a biomedical HIV prevention intervention for reducing HIV incidence in this very high-risk group of MSM.
Primary Outcome
Time to initiation is defined as the number of hours between exposure to viral inoculum and initiation of the Truvada medication regimen.
Conditions Studied
Interventions
- DRUG Truvada
Study Locations (1)
California
- Friends Community Center, A Division of Friends Research Institute, Inc. - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 170 participants |
| Start Date | 2010-05 |
| Est. Completion | 2013-03 |
| Phase | Phase 2 |
What the finished NCT01140880 record still lists
NCT01140880 is an interventional study that assigns participants to a tested intervention. The registered 170 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (28% higher).
The record links to 2 conditions, with Stimulant Abuse appearing as the primary indexed condition, and to 1 intervention - of which Truvada is the first listed.
NCT01140880 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT01140880 about?
NCT01140880 is a clinical study titled "Biobehavioral Interventions for HIV-negative, Stimulant Using Men Who Have Sex With Men". This study seeks to evaluate the efficacy of a contingency management (CM) intervention compared to a yoked control condition for eliminating illicit stimulant use and for decreasing time to initiating post exposure prophylaxis (PEP), for improving adherence to PEP, and for completing PEP following ...
What is the current status of trial NCT01140880?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 170 participants. The study started on 2010-05. Estimated completion is 2013-03.
What conditions does trial NCT01140880 study?
This clinical trial studies the following conditions: Stimulant Abuse, HIV Seroconversion.
What interventions are being tested in trial NCT01140880?
The interventions under investigation include: Truvada (DRUG).
Who is sponsoring clinical trial NCT01140880?
This trial is sponsored by Friends Research Institute, which has 41 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01140880 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stimulant Abuse
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01140880's enrollment target sits among peer trials
170 399th of 2000 higher than 1,598 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02016430 · 170 participants · NA
Gut Flora Metabolite Reduction After Dietary Intervention (GRADY)
- NCT02621021 · 170 participants · Phase 2
A Phase 2 Trial for Metastatic Melanoma Using Adoptive Cell Therapy With Tumor Infiltrating Lymphocytes Plus IL-2 Either Alone or Following the Administration of Pembrolizumab
- NCT04094701 · 170 participants · NA
Hip Arthroscopy Postoperative Opioid Demands
- NCT04166409 · 170 participants · Phase 3
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia